Skip to main content
Caplight Logo









Kneu Health

Kneu Health

Private
LondonHealthcare & Life Scienceshttps://www.kneu.com/

Last Round

Grant

Mar 11, 2026

Total Funding Raised

$9.43M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kneu Health is a healthtech company that provides a smartphone-based clinical platform using AI to monitor symptoms for Parkinson's disease and dementia.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Health IoT, Medical Devices, Patient Engagement, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

remote patient monitoringRPMchronic care managementCCMdigital health platformtelehealth platformvirtual carechronic condition managementconnected medical devicesprovider dashboardhealthcare SaaSpatient engagement appRPM billinghospital at homegovernment health contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kneu Health Comparables

Compare Kneu Health with similar companies based on industry and business-model similarity.

Kneu Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Optimize Health
78%
Vitalist Inc.
72%
RemeCare
70%

Kneu Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 11, 2026
SeedOct 9, 2025
VC RoundJan 29, 2025
AcceleratorAug 1, 2024
Pre SeedOct 19, 2023

Key People

Founding team and executive leadership

Kinan Muhammed

Co-Founder & Chief Medical Officer

Founding Team

Caroline Cake

Chief Executive Officer

Executive Team

Hanson Chow

Chief Technology Officer

Executive Team

Kneu Health Investors

Notable investors and investment history

Kneu Health investors
InvestorRounds
G. K. Goh Holdings Pte. Ltd.Seed
Social Impact EnterprisesSeed
Oxford Science EnterprisesVC Round, Pre Seed, Seed
JIMCOSeed
Cedars-Sinai AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2025

    $6M round led by Oxford Science Enterprises and Cedars-Sinai.

  • Jan 29, 2025

    $2M round with Oxford Science Enterprises and Cedars-Sinai.

Kneu Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kneu Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kneu Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range24
Year Founded2023
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?